Docking Studies and Ligand Recognition for Allosteric Modifiers of Hemoglobin
Poster Apr 07, 2006
M.Cristina De Rosa, Donato Mosca, Cristiana Carelli Alinovi and Bruno Giardina
AbstractOxygen binding affinity of hemoglobin can be modulated by various natural and synthetic allosteric effectors. There is considerable interest in designing agents that produce low-affinity Hbs. Such agents have several potential clinical applications. The aim of this study is to show how a molecular docking strategy can be successfully used to investigate the inhibition mechanism of these synthetic compounds.
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019